Researchers develop new method for early breast cancer detection

FHS
July 19, 2023
11:07 am

A research team from PSI and ETH Zurich, together with the Baden Cantonal Hospital and University Hospital Zurich, wants to improve a method used for diagnosing breast cancer.

Biogen joins immunology wave with $1.15 billion acquisition

Biogen is joining the industry’s fervor over immune and inflammatory disease drug development with a new acquisition. The Cambridge, Mass., drugmaker announced Wednesday that it

May 22, 2024

Friend, not foe: How AI will revolutionize patient care

Editor’s Note: Stacey Churchwell is vice president and general manager of cardiovascular diagnostics and services at Medtronic. Views are the author’s own. Artificial Intelligence, or

September 29, 2023

Novel PARP1 Inhibitor Shows Promise in Breast Cancer

SAN DIEGO — Saruparib, an investigational selective PARP1 inhibitor, showed promising activity in patients with certain homologous recombination repair (HRR)-deficient breast cancers, while limiting toxicity,

April 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.